Cheng et al. showed that hepatocellular cancer-associated fibroblasts induce PD-L1+ neutrophils through the IL-6-STAT3 pathway, which impairs T-cell function, inducing immune suppression through the PD1/PD-L1 signaling pathway [51]. Here, IL6 is linked to hepatocellular carcinoma.